Haoxi Health (HAO) Closes $9.6M IPO, Shares Trading on Nasdaq

TL;DR

**Haoxi Health (HAO) just closed its $9.6M IPO, now officially trading on Nasdaq!**

AI Summary

Haoxi Health Technology Limited (HAO) successfully closed its Initial Public Offering (IPO) on January 30, 2024, issuing 2,400,000 Class A ordinary shares at $4.00 per share. This IPO, managed by EF Hutton LLC, raised $9.6 million for the company, with shares commencing trading on the Nasdaq Capital Market under the ticker "HAO" on January 26, 2024. This matters to investors because it signifies the company's successful entry into the public market, providing capital for growth and establishing a public valuation for its shares.

Why It Matters

The successful closing of the IPO provides Haoxi Health with significant capital for its operations and growth, while also establishing a public market for its shares, which can increase liquidity and visibility for investors.

Risk Assessment

Risk Level: medium — While the IPO is complete, newly public companies often face volatility and execution risks as they adapt to public market scrutiny and utilize their new capital.

Analyst Insight

Investors should monitor HAO's post-IPO performance and how it utilizes the $9.6 million capital to assess its growth trajectory and long-term potential, especially given its listing on Nasdaq.

Key Numbers

• $4.00 — per share IPO price (the price at which Class A Ordinary Shares were sold in the IPO)
• 2,400,000 — Class A ordinary shares (the total number of shares offered in the IPO)
• $0.0001 — par value per share (the nominal value of each Class A ordinary share)
• $9.6 million — total IPO proceeds (calculated from 2,400,000 shares at $4.00 each)

Key Players & Entities

• Haoxi Health Technology Limited (company) — the company that completed the IPO
• EF Hutton LLC (company) — the sole book-running manager for the IPO
• Nasdaq Capital Market (company) — the stock exchange where shares are listed
• January 30, 2024 (date) — the closing date of the IPO
• January 26, 2024 (date) — the date shares commenced trading
• August 25, 2023 (date) — initial filing date of Form F-1
• January 25, 2024 (date) — effective date of Form F-1 and date of underwriting agreement

Forward-Looking Statements

• Haoxi Health will use the IPO proceeds to expand its advertising services in China. (Haoxi Health Technology Limited) — medium confidence, target: 2025-01-30
• The stock price of HAO will experience significant volatility in its first year of trading. (HAO) — high confidence, target: 2025-01-30

FAQ

Key Financial Figures

• $0.0001 — ,000 Class A ordinary shares, par value $0.0001 per share (the “Class A Ordinary
• $4.00 — Class A Ordinary Shares were priced at $4.00 per share, and the offering was conduct
• $9,600,000 — Technology Limited Announces Closing of $9,600,000 Initial Public Offering 3

Filing Documents

• ea192481-6k_haoxihealth.htm (6-K) — 13KB
• ea192481ex99-1_haoxihealth.htm (EX-99.1) — 11KB
• ea192481ex99-2_haoxihealth.htm (EX-99.2) — 10KB
• 0001213900-24-008008.txt ( ) — 35KB

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Haoxi Health Technology Limited Date: January 30, 2024 By: /s/ Zhen Fan Name: Zhen Fan Title: Chief Executive Officer 2 EXHIBIT INDEX Exhibit No. Description 99.1 Press Release – Haoxi Health Technology Limited Announces Pricing of Its Initial Public Offering 99.2 Press Release – Haoxi Health Technology Limited Announces Closing of $9,600,000 Initial Public Offering 3

View Full Filing

View this 6-K filing on SEC EDGAR